Premium
POLA‐R‐CHP: POLATUZUMAB VEDOTIN COMBINED WITH RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISONE FOR PATIENTS WITH PREVIOUSLY UNTREATED DIFFUSE LARGE B‐CELL LYMPHOMA
Author(s) -
Tilly H.,
Sharman J.,
Bartlett N.,
Morschhauser F.,
Haioun C.,
Munoz J.,
Chen A.,
Lamy T.,
Wang L.,
Penuel E.,
Hirata J.,
Lee C.,
Salles G.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2437_79
Subject(s) - medicine , rituximab , prednisone , cyclophosphamide , diffuse large b cell lymphoma , gastroenterology , vincristine , lymphoma , surgery , oncology , chemotherapy